RSV Dominates Bronchiolitis Cases

As of today, October 30, 2025,‍ between 75%​ adn 80% of bronchiolitis cases in children are attributed to Respiratory Syncytial Virus (RSV). This marks a significant⁣ period of increased infection rates,particularly impacting infants ⁢and young children.

Bronchiolitis is a common lung infection that primarily affects babies and young children.It causes inflammation and⁢ congestion in the small airways ​of the lungs.While various viruses can cause bronchiolitis, RSV is the most frequent culprit. ⁢ According to the ⁣ Centers for‌ Disease Control ​and Prevention (CDC), nearly all children will have an RSV infection by age two.

Rapid Spread and Transmission

Dr.Al-Ghard,speaking to⁤ Al-Shabab Radio,highlighted the virus’s rapid transmission rate. ⁢ RSV can survive for over 30 minutes on hands and for⁤ hours on surfaces like clothing,⁤ facilitating easy spread within families and childcare settings.

This ease of transmission underscores the importance of diligent hygiene practices.RSV spreads through‍ droplets produced when an infected person coughs or sneezes. It can also spread through direct contact, such as touching a contaminated⁣ surface⁣ and than ​touching the face, and through indirect contact.‌

Preventive Measures and Hospitalizations

Dr.Al-Ghard emphasized the necessity of regular handwashing​ and adherence to⁤ preventative measures, particularly as the virus is currently widespread in numerous regions. ‌ The increase in RSV infections is a primary driver of hospitalizations among young children in ‌recent weeks.

Preventative measures ‍include:

• Frequent handwashing with soap and water for at least ​20 seconds.
• Covering coughs and sneezes with a tissue or elbow.
• Avoiding close contact with​ sick individuals.
• Disinfecting frequently touched surfaces.
• Keeping children ​home when they are sick.

Who is at Risk?

RSV is a ⁢common seasonal virus, typically circulating during the fall and winter months.⁢ While most⁣ children experience mild, cold-like symptoms, RSV can cause severe illness, especially ⁢in:

• Infants, particularly those younger than six months.
• premature infants.
• Children with underlying‌ health conditions,such as heart or lung disease,or weakened immune systems.
• Older adults with ⁣chronic medical conditions.

Severe RSV infection can lead to bronchiolitis and ‌pneumonia, requiring hospitalization. The World Health Organization (WHO) estimates that RSV causes approximately 33 million cases of acute lower ‌respiratory infections each year in children under five, leading‌ to over 3 million hospitalizations.

Recent Developments & Future Outlook

In May 2023, the FDA approved the first RSV vaccine for older adults, Arexvy,‍ manufactured by GSK. Additionally, in June 2023, the FDA approved ‌ Beyfortus, a monoclonal antibody for infants to prevent RSV. ‍These advancements offer new avenues for protection against RSV.

Continued monitoring of RSV trends and adherence to ⁣public health ​recommendations are crucial to mitigating the impact of⁣ this virus, especially during peak season